Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MMP13 | P45452 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12722242 | 0.95 | LMNA (0.50) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL677362 | 0.92 | LMNA (0.47) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL241601 | 0.87 | LMNA (0.61) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL15763957 | 0.85 | KIF11 (0.50) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL2703212 | 0.84 | ALDH1A1 (0.47) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL15827154 | 0.84 | LMNA (0.53) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL13633980 | 0.83 | KMT2A (0.51) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL18295376 | 0.83 | LMNA (0.49) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL410353 | 0.83 | LMNA (0.48) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL12300578 | 0.82 | LMNA (0.74) | LMNAGAAKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170166513-A1 | EPOXY RESIN CURING AGENT AND PREPARATION METHODS AND USES THEREOF | GUANGDONG GUANGSHAN NEW MATERIALS CO., LTD. (CN) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166513-A1 | EPOXY RESIN CURING AGENT AND PREPARATION METHODS AND USES THEREOF | EPHX1, EPHX2, EED | LMNA 773/4885GAA 2063/4885KMT2A 592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.